Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer Journal

Publication venue for

Immunotherapy adverse events predict treatment response. 7. 2019
Preliminary results of a Phase 1 trial with a personalized neoantigen vaccine (ADXS-NEO) in advanced and refractory cancer patients. 7. 2019

International Standard Serial Number (ISSN)

2051-1426